Continuing bisphosphonate treatment for osteoporosis--for whom and for how long?
Continuing bisphosphonate treatment for osteoporosis--for whom and for how long?
复制标题
DOI：
10.1056/nejmp1202623
复制
发表时间：
2012-05-31
期刊：
影响因子：
--
通讯作者：
Rosen CJ
中科院分区：
文献类型：
--
作者：
Black DM;Bauer DC;Schwartz AV;Cummings SR;Rosen CJ
鉴于非典型转子下骨折和颌骨坏死的报道，双磷酸盐治疗骨质疏松症的理想持续时间存在争议。但某些亚组患者可能会受益于 3 至 5 年以上的持续治疗。
There is controversy over the ideal duration of bisphosphonate therapy for osteoporosis, given reports of atypical subtrochanteric fractures and osteonecrosis of the jaw. But some subgroups of patients may benefit from continuing therapy beyond 3 to 5 years.